Brokers Offer Predictions for Teladoc Health FY2024 Earnings

Teladoc Health, Inc. (NYSE:TDOC) – Investment analysts at Zacks Research upped their FY2024 EPS estimates for Teladoc Health in a research note issued on Wednesday, November 13th. Zacks Research analyst R. Department now forecasts that the health services provider will post earnings per share of ($1.15) for the year, up from their prior forecast of ($1.31). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.17) per share. Zacks Research also issued estimates for Teladoc Health’s Q4 2024 earnings at ($0.19) EPS, Q1 2025 earnings at ($0.38) EPS, Q2 2025 earnings at ($0.28) EPS, Q3 2025 earnings at ($0.27) EPS, Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($1.05) EPS, Q1 2026 earnings at ($0.37) EPS, Q2 2026 earnings at ($0.22) EPS, Q3 2026 earnings at ($0.21) EPS and FY2026 earnings at ($0.89) EPS.

Several other research analysts have also issued reports on TDOC. TD Cowen cut their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday, October 31st. Oppenheimer cut their price objective on shares of Teladoc Health from $21.00 to $17.00 and set an “outperform” rating on the stock in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft boosted their target price on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. The Goldman Sachs Group started coverage on Teladoc Health in a report on Friday. They issued a “buy” rating and a $14.00 price target on the stock. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price objective on shares of Teladoc Health in a research note on Tuesday, August 20th. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $12.08.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $9.21 on Monday. The firm has a 50 day moving average of $8.89 and a 200-day moving average of $9.36. The company has a market cap of $1.59 billion, a price-to-earnings ratio of -1.60 and a beta of 0.90. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.54.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Rubric Capital Management LP bought a new position in shares of Teladoc Health in the second quarter worth $45,267,000. Point72 Asset Management L.P. lifted its holdings in Teladoc Health by 221.9% during the 2nd quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider’s stock worth $51,865,000 after purchasing an additional 3,655,436 shares in the last quarter. Clearline Capital LP boosted its stake in Teladoc Health by 395.6% in the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after purchasing an additional 3,483,665 shares during the period. Assenagon Asset Management S.A. purchased a new position in Teladoc Health during the 3rd quarter valued at about $15,801,000. Finally, Maple Rock Capital Partners Inc. bought a new stake in shares of Teladoc Health during the third quarter valued at about $11,291,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Insider Buying and Selling at Teladoc Health

In related news, COO Michael Willem Waters sold 4,218 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $30,200.88. Following the completion of the sale, the chief operating officer now owns 78,309 shares in the company, valued at approximately $560,692.44. This trade represents a 5.11 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Mala Murthy sold 8,750 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the transaction, the chief financial officer now owns 85,767 shares in the company, valued at approximately $614,091.72. The trade was a 9.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 20,051 shares of company stock worth $143,565. Insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.